AEM Accepted Manuscript Posted Online 10 April 2015 Appl. Environ. Microbiol. doi:10.1128/AEM.00527-15 Copyright © 2015, American Society for Microbiology. All Rights Reserved.
1
Running title: D-Lactate Utilization of Gluconobacter oxydans
2 3
Utilization of D-Lactate as an Energy Source Supports the Growth of
4
Gluconobacter oxydans
5 6 7
Binbin Sheng,a Jing Xu,a Yingxin Zhang,a Tianyi Jiang,a Sisi Deng,a Jian Kong,a Chao
8
Gao,a,# Cuiqing Ma,a and Ping Xub
9 10
State Key Laboratory of Microbial Technology, Shandong University, Jinan 250100,
11
People’s Republic of Chinaa;
12
State State Key Laboratory of Microbial Metabolism and School of Life Sciences and
13
Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, People’s Republic of
14
Chinab
15 16
#
17
Phone: +86-531-88364003; Fax: +86-531-88369463;
18
Mailing address: State Key Laboratory of Microbial Technology, Shandong University,
19
Jinan 250100, People’s Republic of China.
Corresponding author: Chao Gao; E-mail:
[email protected];
20
1
21
ABSTRACT
22
D-Lactate
23
growth of Gluconobacter oxydans 621H in this study. Interestingly, this strain used
24
D-lactate
25
lactate-utilizing bacteria. The enzymatic basis for the growth of G. oxydans 621H on
26
D-lactate
was therefore investigated. Although two putative NAD-independent
27
D-lactate
dehydrogenases, GOX1253 and GOX2071, were capable of oxidizing
28
D-lactate,
GOX1253 was the only enzyme able to support the D-lactate-driven
29
growth of the strain. GOX1253 was characterized as a membrane-bound
30
dehydrogenase with a high activity towards D-lactate, while GOX2071 was
31
characterized as a soluble oxidase with broad substrate specificity towards
32
D-2-hydroxy
33
feature that has not been reported previously in D-lactate oxidizing enzymes. This
34
study not only clarifies the mechanism for the growth of G. oxydans on D-lactate, but
35
also provides new insights for applications of the important industrial microbe and
36
the novel D-lactate oxidase.
was identified as one of a few available organic acids that supported the
as an energy source but not as a carbon source, unlike other
acids. The latter used molecular oxygen as a direct electron acceptor, a
37
2
38
INTRODUCTION
39
Gluconobacter oxydans is a Gram-negative, rod-shaped, obligate aerobic bacterium. The
40
genomic information of G. oxydans 621H suggests that this bacterium harbors
41
functionally impaired Embden-Meyerhof-Parnas (EMP) pathway and tricarboxylic acid
42
(TCA) cycle (1-2). The respiratory chain of G. oxydans is different from other aerobic
43
bacteria; it does not rely on NADH as an electron donor (1). Thus, the major function of
44
the EMP pathway and TCA cycle in G. oxydans is to provide biosynthetic precursors (3).
45
The energy supply in G. oxydans favors a mode of action, in which numerous
46
dehydrogenases oxidize their substrates incompletely under growth conditions (2). High
47
oxidation rates, correlating with low growth yields, give G. oxydans a unique capability of
48
enabling the rapid and incomplete oxidation of a wide range of sugars and alcohols and
49
make the strain a promising biocatalyst in a variety of biotechnological processes (3-7).
50
However, relatively little is known about the membrane-bound and soluble
51
dehydrogenases that catalyze the oxidation of specific substrates.
52
In nature, G. oxydans mainly grows in sugary, acidic, and alcoholic niches including
53
flowers, fruits, garden soil, cider, wine, and beer (3-4). The habitats of G. oxydans contain
54
numerous organic compounds, such as sugars, alcohols, amino acids, and organic acids.
55
Utilization of these organic compounds is vital for the survival of G. oxydans. The growth
56
of G. oxydans 621H on various sugars and alcohols has been investigated in detail (8).
57
Sugars and alcohols in the habitats of G. oxydans are usually oxidized rapidly, providing
58
electrons for the generation of energy. The oxidation products, such as sugar acids, are
59
difficult for other organisms to assimilate; when released into the environment, they
60
inhibit the growth of competitors by lowering the pH (2). However, it is not known
61
whether G. oxydans can use amino acids and organic acids, the two other types of 3
62 63
compounds extensively distributed in nature, to support its growth. Many bacteria, such as Escherichia coli (9-10), Corynebacterium glutamicum (11),
64
and Pseudomonas stutzeri (12), are able to utilize lactate for growth. During the lactate
65
utilization process in these bacteria, lactate is first oxidized to pyruvate; pyruvate is then
66
used as both carbon and energy sources to support the growth of these bacteria. Lactate
67
can be oxidized to pyruvate by NAD-dependent lactate dehydrogenases (nLDHs) and
68
NAD-independent lactate dehydrogenases (iLDHs) (13). The nLDHs often play
69
important roles in anaerobic fermentation to produce lactate from pyruvate (14-15). The
70
iLDHs usually serve as the key enzymes to support the growth of microorganisms on
71
lactate (9, 11-13). Furthermore, the iLDHs can be divided into D-iLDHs and L-iLDHs
72
according to their chiral specificity. Most characterized iLDHs are membrane-bound
73
proteins that use quinones or cytochrome c as native electron acceptors (13). Two
74
untypical L-iLDHs, L-lactate oxidase and L-lactate monooxygenase, use O2 directly as an
75
electron acceptor (13). Based on this feature, these two L-iLDHs are widely used in
76
biosensor and biocatalysis applications (16-18). However, no D-iLDH that directly uses
77
O2 as an electron acceptor has been reported (13).
78
In this study, we found that G. oxydans 621H is unable to utilize almost all amino
79
acids and most common organic acids for growth. Only several 2-hydroxy acids,
80
particularly D-lactate, supported the growth of G. oxydans 621H. However, pyruvate, the
81
product of D-lactate oxidation, did not support the growth of G. oxydans in our
82
observations. Thus, the driving force of D-lactate on G. oxydans 621H growth should
83
derive solely from the process of D-lactate oxidation. To understand the utilization of
84
D-lactate
85
and identified two putative D-iLDHs (GOX1253 and GOX2071). The two putative
by G. oxydans 621H, we analyzed its genome, which was sequenced in 2005 (1),
4
86
D-iLDHs
were characterized and their physiological functions were investigated to clarify
87
the unusual mechanism of G. oxydans growth on D-lactate. Interestingly, we also found
88
that GOX2071 is a novel type of D-iLDH that uses O2 as an electron acceptor, with which
89
GOX2071 may be useful in biosensor and biocatalysis applications.
90 91
MATERIALS AND METHODS
92
Bacterial strains and culture conditions. The bacterial strains and plasmids used in this
93
study are listed in Table 1. G. oxydans 621H (DSM 2343) and its derivatives were
94
cultivated routinely in Y-S medium containing 80 g sorbitol, 24 g yeast extract, 5 g
95
(NH4)2SO4, 2 g KH2PO4, and 5 g MgSO4·7H2O in 1 l of distilled water at 200 rpm and
96
30°C (7, 19). Before G. oxydans 621H was inoculated to other mediums, the cells were
97
washed with 0.85 % NaCl solution to remove the residual Y-S medium thoroughly. In the
98
assays to compare the growth of G. oxydans 621H on different organic compounds, G.
99
oxydans 621H was cultured in the mediums (pH 6.0) containing 5 g/l yeast extract and 3
100
g/l peptone (abbreviated as YE-P medium) supplemented with 50 mM of D-glucose,
101
1,2-propanediol, 19 proteinaceous amino acids except for tyrosine, or 24 organic acids,
102
respectively. Tyrosine was not assayed as it would be precipitated at 50 mM once below
103
pH 10. In the experiment of determination of the growth curve, G. oxydans 621H and its
104
derivatives were cultivated in 500-ml shaking flasks filled with 50 ml liquid YE-P
105
medium supplemented with 50 mM of D-lactate or pyruvate, respectively. E. coli strains
106
were cultured in Luria–Bertani (LB) medium supplemented with appropriate antibiotics
107
at 180 rpm and 37°C. Antibiotics were added, if necessary, at the following
108
concentrations unless otherwise stated: cefoxitin at 50 μg/ml, kanamycin at 50 μg/ml, and
109
ampicillin at 100 μg/ml. 5
110
Deletion and complementation of GOX1253 and GOX2071 encoding genes. To
111
delete the gene of GOX1253 in G. oxydans 621H, the homologous arms of upstream and
112
downstream of the target GOX1253 gene were PCR amplified by using the primers
113
GOX1253up.f/GOX1253up.r and GOX1253down.f/GOX1253down.r (Table 2). Then,
114
they were fused together via recombinant PCR by using the primers GOX1253up.f and
115
GOX1253down.r, which contained EcoRI and HindIII restriction enzyme sites,
116
respectively (Table 2). The generated fusion construct and pK18mobsacB (20), a
117
mobilizable plasmid that does not replicate in G. oxydans, were digested with EcoRI and
118
HindIII, respectively, and were then linked by using T4 DNA ligase to form
119
pK18mobsacB-ΔGOX1253. The plasmid was transferred into G. oxydans via a triparental
120
mating method as described previously (21). E. coli DH5α harbouring
121
pK18mobsacB-ΔGOX1253 was used as the donor strain, E. coli HB101 harbouring the
122
plasmid pRK2013 as the helper strain, and G. oxydans 621H as the recipient strain. The
123
Y-S medium agar plate supplemented with 50 μg/ml kanamycin, 50 μg/ml cefoxitin, and
124
0.1% acetic acid (v/v) was used for screening single crossover mutant, in which acetic
125
acid was used to eliminate E. coli growth (22). The mutants lost GOX1253 gene in a
126
second homologous recombination were screened from the Y-S medium agar plate
127
containing 10% sucrose. The ΔGOX1253 mutant was checked by PCR and sequenced by
128
using primers GOX1253up.f and GOX1253down.r. Thereafter, the mutants, G. oxydans
129
ΔGOX2071 and G. oxydans ΔGOX1253 ΔGOX2071, were constructed with the same
130
method by using the primers GOX2071up.f/GOX2071up.r and
131
GOX2071down.f/GOX2071down.r (Table 2).
132 133
For the complementation of GOX1253 and GOX2071, fragments GOX1253 and GOX2071 were amplified by PCR using G. oxydans 621H genome as template and using 6
134
GOX1253up.f/GOX1253down.r and GOX2071up.f/GOX2071down.r as primers,
135
respectively (Table 2). The resulting PCR products were cloned into EcoRI/HindIII-cut
136
pBBR1p264, a broad-host-range plasmid with a strong promoter derived from
137
pBBR1MCS2 and used for the expression of proteins in G. oxydans (23). The resulting
138
plasmids, pBBR1p264-GOX1253 and pBBR1p264-GOX2071, were conjugated into G.
139
oxydans ΔGOX1253 ΔGOX2071 via the triparental mating method mentioned above.
140
Purification of recombinant GOX1253 and GOX2071. The genes encoding
141
GOX1253 and GOX2071 were amplified by PCR using genome of G. oxydans 621H as
142
template and GOX1253C.f/GOX1253C.r and GOX2071C.f/GOX2071C.r as primers,
143
respectively (Table 2). The PCR product of GOX1253 and pET25b were digested by
144
NdeI and HindIII and linked by T4 DNA ligase to construct plasmid pET25b-GOX1253.
145
The PCR product of GOX2071 was digested by NdeI and XhoI and cloned into
146
NdeI-XhoI sites of pET25b to form plasmid pET25b-GOX2071. The resulting plasmids
147
were separately transformed into E. coli C43 (DE3) (24) for protein expression. The
148
recombinant E. coli strains were cultured in LB medium containing 100 μg/ml ampicillin
149
at 37°C and 180 rpm to optical density of 0.4 ~ 0.6 at 600 nm, then 1 mM
150
isopropyl-β-D-1-thiogalactopyranoside (IPTG) was added to induce protein expression.
151
Cultures of E. coli C43 (pET25b-GOX1253) were grown at 16°C for a further 10 h, while
152
E. coli C43 (pET25b-GOX2071) were further incubated at 37°C for 6 h. Thereafter, cells
153
were harvested and washed twice in 67 mM phosphate buffer (pH 7.4) at 3,400 × g for 10
154
min at 4°C.
155
E. coli C43 (pET25b-GOX1253) cells were suspended in binding buffer (pH 7.4, 20
156
mM sodium phosphate and 500 mM sodium chloride) supplemented with 0.1% Triton
157
X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 10% glycerol, and disrupted 7
158
by sonication with a sonics sonicator (500 W/20 KHz, USA) on ice bath. Intact cells and
159
cell debris were removed by centrifugation at 13,500 × g and 4°C. The resultant
160
supernatant was applied to a HisTrap HP column (5 ml) equilibrated with binding buffer
161
supplemented with 0.1% Triton X-100, and eluted with a gradient ratio of elution buffer
162
(pH 7.4, 20 mM sodium phosphate, 500 mM imidazole, and 500 mM sodium chloride)
163
supplemented with 0.1% Triton X-100 to obtain purified GOX1253.
164
E. coli C43 (pET25b-GOX2071) cells were suspended in buffer A (pH 7.4, 20 mM
165
sodium phosphate) supplemented with 1 mM PMSF, and 10% glycerol, disrupted by
166
sonication, and centrifuged to remove intact cells and cell debris. The resultant
167
supernatant was first loaded onto a Source 30Q column (2.5 × 25 cm) equilibrated with
168
buffer A and eluted with a gradient ratio of buffer B (pH 7.4, 20 mM sodium phosphate,
169
500 mM sodium chloride). The fractions containing D-iLDH activity were collected and
170
then applied to a HisTrap HP column (5 ml). Thereafter, GOX2071 was purified with
171
gradient elution by using elution buffer.
172
The purified enzymes were concentrated by ultrafiltration. Finally, GOX1253 was
173
stored in 50 mM Tris-HCl buffer (pH 7.4) supplemented with 0.1% Triton X-100, and
174
GOX2071 was stored in 50 mM Tris-HCl buffer (pH 7.4).
175
Ultracentrifugation for iLDHs localization. After cultured for 20 h, cells of G.
176
oxydans 621H and its derivatives were harvested, washed twice with 67 mM phosphate
177
buffer solution (pH 7.4), and resuspended in 20 mM phosphate buffer solution (pH 7.4)
178
containing 1 mM PMSF. Then the suspension of the resulting cells was disrupted by a
179
pressure cell homogenizer (Stansted Fluid Power LTD, UK) at a pressure of 1.5 bars.
180
Intact cells were removed by conventional centrifugation at 13,500 × g and 4°C for 5 min.
181
Thereafter, the resultant crude extract of 4 ml was ultra-centrifuged at 150,000 × g and 8
182
4°C for 2 h. The resulting precipitate was completely separated from the
183
ultracentrifugation supernatant, and subsequently suspended in the buffer of 4 ml, and
184
then subjected to successive enzyme determination.
185
Determination of iLDH activity using MTT as an electron acceptor. The activity
186
of iLDH was assayed at 30°C in 0.8 ml of 50 mM Tris-HCl buffer (pH 7.4) containing 10
187
mM D-lactate or L-lactate, 0.2 mM MTT
188
[3-(4,5-dimethylthia-zol-2-yl)-2,5-diphenyltetrazolium bromide], 0.2 mM phenazine
189
methosulfate (PMS), and appropriate crude extracts or enzyme solutions, unless
190
otherwise stated. To determine the substrate specificities of enzymes, 10 mM sodium salts
191
of different 2-hydroxy acids were used instead of lactate. The rate of MTT reduction was
192
determined by measuring the absorbance change at 578 nm. One unit of iLDH activity
193
was defined as the amount that catalyzed the reduction of 1 µmol of MTT per minute.
194
The protein concentration was determined by the Lowry procedure by using bovine
195
serum albumin as the standard (25).
196
Detection of D-lactate oxidase activity and its kinetics. D-Lactate oxidase activity
197
was measured at 30°C in 500 μl reaction solution, which contained 50 mM Tris-HCl (pH
198
7.4), 20 mM D-lactate, and enzyme, using a Clark-type oxygen electrode (Oxytherm,
199
Hansatech, UK) equipped with automatic temperature controlled electrode chamber at
200
900 rpm. One unit of oxidase activity was defined as the amount that catalyzed the
201
reduction of 1 µmol of O2 per minute.
202
To determine the apparent Km for O2, oxygen consumption was measured in 50 mM
203
Tris-HCl buffer (pH 7.4) containing various concentrations of O2, appropriate enzyme,
204
and 20 mM D-lactate, using a Clark-type oxygen electrode. The initial O2 levels in
205
reaction solution were varied by mixture of O2-saturated and N2-saturated Tris-HCl 9
206
buffers (pH 7.4). When measuring the apparent Km for D-lactate, air-saturated Tris-HCl
207
buffer was used. Lineweaver-Burk double-reciprocal plots were utilized to determine the
208
apparent kinetic parameters.
209
Analytical procedures. The sodium dodecyl sulfate-polyacrylamide gel
210
electrophoresis (SDS-PAGE) was performed as reported previously (26). For
211
size-exclusion chromatography analysis, protein samples were loaded onto a Superdex
212
200 10/300 GL column (GE Healthcare) equilibrated with a buffer C (pH 7.2, 50 mM
213
phosphoric acid, and 0.15 M NaCl) at a flow rate of 0.5 ml/min. Standard proteins,
214
thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa),
215
ovalbumin (43 kDa), and ribonuclease A (13.7 kDa), were used for standard curve.
216
To determine the flavin cofactor of the purified proteins, standard flavins including
217
FAD, FMN, and riboflavin were measured with high performance liquid chromatography
218
(HPLC) (Agilent 1100 series) equipped with an Agilent Zorbax Eclipse XDB-C18 column
219
(150 × 4.6 mm, 5 µm) and a variable-wavelength detector at 450 nm (27). The mobile
220
phase consisted of 50 mM (NH4)2CO3 and methanol with a ratio of 82:18 (v/v) at a flow
221
rate of 0.5 ml/min at 30°C (27). The purified proteins were heated at 100°C for 10 min,
222
and then centrifuged at 16,000 × g for 15 min to remove denatured proteins. The resultant
223
supernatants containing the cofactors released from the purified enzymes were analyzed
224
with HPLC to identify the type of the cofactor. Standard FAD solutions of 1, 2, 5, 10, 20,
225
40, 80, 120 µM were detected at 450 nm, and used for quantitative analysis.
226
Lactate, pyruvate, and acetate were measured using HPLC equipped with an Aminex
227
HPX-87H column (300 mm × 7.8 mm, 9 µm) and a differential refractive index detector
228
(RID) (28). The mobile phase was 10 mM H2SO4 at a flow rate of 0.4 ml/min at 55°C.
229 10
230
RESULTS
231
D-Lactate
232
oxydans can thrive by using sugars and polyols, such as glucose and sorbitol, as the sole
233
carbon and energy source (7-8, 29). To determine whether the strain can also grow by
234
using the two other types of organic compounds widely found in nature, amino acids and
235
organic acids, the growth of G. oxydans 621H on 19 proteinaceous amino acids and 24
236
organic acids was investigated. D-Glucose and 1,2-propanediol were used as positive
237
controls. As shown in Fig. 1A, after cultured for 24 h, the OD600 nm increased by more
238
than 0.5 when G. oxydans 621H was grown on D-glucose and 1,2-propanediol, whereas
239
no obvious growth was observed on proteinaceous amino acids, when compared with the
240
growth of the negative control. With regard to the 24 organic acids used in this study
241
(including glyoxylate; common hydroxy acids such as glycolate, D-/L-lactate, and
242
D-/L-mandelate;
243
oxalate, and citrate), only lactate, particularly D-lactate, supported the growth of G.
244
oxydans 621H obviously (Fig. 1B).
245
serves as an energy source to support growth of G. oxydans 621H. G.
and other common mono-, di-, and tri-carboxylic acids such as formate,
The robust growth of G. oxydans 621H on D-lactate (Fig. 2A) was accompanied by
246
the rapid consumption of D-lactate (Fig. 2B) and the accumulation of pyruvate and
247
acetate (Fig. 2C and 2D), indicating that D-lactate was first oxidized to pyruvate during
248
the growth of G. oxydans 621H on D-lactate. However, when G. oxydans 621H was
249
cultured on pyruvate, little growth was detected when compared with the control. This
250
suggests that the energy obtained from the oxidation of D-lactate to pyruvate is essential
251
for the growth of G. oxydans 621H on D-lactate.
252 253
G. oxydans 621H contains two D-lactate oxidizing enzymes. One mole of D-lactate provides two moles of electrons for the respiratory chain during the redox process (9). 11
254
The electrochemical proton gradient generated by the electron transport chain in G.
255
oxydans 621H is used to generate ATP via an F1F0-type ATP synthase (1). D-Lactate, but
256
not pyruvate, supported the growth of G. oxydans 621H, implying that the energy
257
obtained from the oxidation of D-lactate to pyruvate was crucial for the growth of G.
258
oxydans 621H on D-lactate. To understand the D-lactate oxidation process, the D-lactate
259
oxidizing activity of G. oxydans 621H was assayed. G. oxydans 621H cells cultured in
260
Y-S medium were broken using a high press cracker to obtain a crude cell extract, and the
261
activities of iLDHs in G. oxydans 621H were assessed using MTT as an electron acceptor
262
and D-lactate or L-lactate as the substrate. As shown in Table 3, both D-iLDH and L-iLDH
263
activities were detected. The activity towards D-lactate was approximately 8-fold higher
264
than the activity towards L-lactate. After ultracentrifugation, the major D- and L-iLDH
265
activities were found in the membrane fractions, but a low D-iLDH activity remained in
266
the supernatant (Table 3). Thus, in addition to a membrane-bound D-iLDH, at least one
267
soluble D-iLDH appeared to be present in the cytoplasm.
268
GOX1253 and GOX2071 are membrane-bound and soluble D-lactate oxidizing
269
enzymes, respectively. Two putative D-iLDHs (GOX1253 and GOX2071) have been
270
annotated in the genome of G. oxydans 621H (1). Comparative genomics analyses were
271
performed to compare their protein sequences with those of well-characterized D-iLDHs
272
(9, 30-32). GOX1253 shows high identity to D-iLDHs from E. coli (YP_490372.1, 55.2%
273
identity) and C. glutamicum (NP_600129.1, 46.4% identity) and low identity to D-iLDHs
274
from Archaeoglobus fulgidus (NP_069230.1, 14.3% identity) and Shewanella oneidensis
275
(NP_717138.2, 8.2% identity). Comparatively, GOX2071 shows relatively high identity
276
to D-iLDH from A. fulgidus (28.2% identity) and low identity to D-iLDHs from E. coli
277
(12.4% identity), C. glutamicum (13.6% identity), and S. oneidensis (8.2% identity). 12
278
To determine the intracellular location of the two putative D-iLDHs in G. oxydans
279
621H, the single and double mutants of GOX1253 and GOX2071, and their respective
280
complemented strains were constructed. The crude extracts were ultracentrifuged, and the
281
D-lactate
282
assayed. As shown in Table 4, no D-iLDH activity was found in the ultracentrifugation
283
supernatant or in the membrane fractions of G. oxydans ΔGOX1253 ΔGOX2071, which
284
indicated that there is no other D-iLDH in G. oxydans 621H. For G. oxydans ΔGOX2071,
285
activity was detected in the membrane fractions, while activity was only detected in the
286
ultracentrifugation supernatant of G. oxydans ΔGOX1253. These results suggest that
287
GOX1253 is a membrane-bound protein, while GOX2071 localizes in the cytoplasm,
288
which is rare for D-iLDHs. These findings were confirmed by the specific activities of G.
289
oxydans ΔGOX1253 ΔGOX2071 complemented with GOX1253 or GOX2071. The
290
unexpected activity in the ultracentrifugation supernatant of the GOX1253 complemented
291
strain was likely attributable to the fact that the overexpressed GOX1253 formed micelles
292
during lysis that did not sediment with the membrane fraction upon ultracentrifugation
293
(33).
oxidizing activities in the resultant supernatants and membrane fractions were
294
Purification and characterization of GOX1253. To characterize GOX1253, the
295
gene encoding GOX1253 was cloned and overexpressed in E. coli C43 (DE3), and the
296
protein with His-tag at its C-terminus was purified using a HisTrap column (Fig. 3A). In
297
size-exclusion chromatography analysis, the size of active GOX1253 calculated
298
according to its retention volume (11.660 ml) was 280.3 kDa (Fig. 3B) and the weight of
299
its monomer was calculated as 67.6 kDa according to its deduced amino acid sequence.
300
Thus, purified recombinant GOX1253 showed a polymerization degree of 4.15,
301
indicating that active GOX1253 exists as a tetramer. The purified GOX1253 solution was 13
302
light yellow with typical flavin absorption peaks around 460 nm and 380 nm, indicating
303
the presence of flavin. The flavin released from denatured GOX1253 by boiling migrated
304
identically with the FAD standard in HPLC, confirming that the flavin was FAD (Fig. 3C).
305
The estimated ratio of GOX1253 monomer to FAD was 2.24 ± 0.02 (Fig. S1). Therefore,
306
the active GOX1253 enzyme appears to contain one FAD per two subunits.
307
To analyze the product of the GOX1253 catalyzed D-lactate dehydrogenation, the
308
reaction solution containing 50 mM Tris-HCl (pH 7.4), 20 mM D-lactate, 2 U/ml purified
309
GOX1253, and 1 mM MTT was incubated aerobically at 30°C and 180 rpm for 30 min,
310
boiled to terminate the reactions and then subjected to HPLC analysis. The reactions with
311
denatured GOX1253 or without MTT addition were also conducted under identical
312
conditions (Fig. 3D). The results showed that pyruvate was obtained from the reaction
313
solution containing 1 mM MTT as an electron acceptor, whereas little pyruvate was found
314
in the reaction solution without MTT. Thus, GOX1253 is a typical D-iLDH that needs
315
artificial electron acceptors for D-lactate oxidation in vitro.
316
Purification and characterization of GOX2071. The gene encoding GOX2071
317
was also cloned and overexpressed in E. coli C43 (DE3). The fold purification and yields
318
of GOX2071 are shown in Table S1. Purified GOX2071 was obtained successively using
319
a Source 30Q column and a HisTrap column (Fig. 4A). In size-exclusion chromatography
320
analysis, the size of active GOX2071 calculated according to its retention volume (13.466
321
ml) was 119.0 kDa (Fig. 4B) while the weight of its monomer was calculated as 54.0 kDa.
322
Thus, active GOX2071 showed a polymerization degree of 2.20, indicating that it exists
323
as a dimer. Purified GOX2071 had an intense yellow color with typical flavin absorption
324
peaks around 460 nm and 380 nm, indicating that GOX2071 is also a flavoprotein. The
325
flavin released from denatured GOX2071 migrated identically with the FAD standard in 14
326
HPLC, confirming that the flavin was FAD (Fig. 4C). The estimated ratio of GOX2071
327
monomer to FAD was 1.15 ± 0.00 (Fig. S1). Thus, active GOX2071 contains one FAD
328
per subunit.
329
The catalytic properties of GOX2071 were investigated in the reaction solutions
330
containing 2 U/ml GOX2071, as described above for GOX1253. In the absence of MTT,
331
when O2 was used as the sole electron acceptor, 1.99 mM pyruvate and 9.52 mM acetate
332
were detected. In comparison, 3.90 mM pyruvate and 6.58 mM acetate were obtained
333
when MTT was present (Fig. 4D). The results indicated that GOX2071 used O2 as a
334
direct electron acceptor, which is consistent with the properties of an oxidase. The higher
335
amount of pyruvate (3.90 mM) and lower amount of acetate (6.58 mM) obtained when
336
MTT was added might reflect competition of MTT with O2 as the direct electron
337
acceptor.
338
Difference between GOX1253 and GOX2071. The substrate specificities of
339
GOX1253 and GOX2071 were determined with 10 mM 2-hydroxy acids with different
340
side chains using MTT as the electron acceptor. Both GOX1253 and GOX2071 preferred
341
D-2-hydroxy
342
22.31 U/mg, GOX1253 had narrow substrate specificity and incomplete stereoselectivity
343
for the D-isomer (i.e., low but detectable activity for L-lactate) (Fig. 5A). Comparatively,
344
GOX2071 showed a relatively low specific activity for D-lactate (0.35 U/mg), but had
345
broad substrate specificity. Furthermore, GOX2071 had higher specific activity towards
346
long-chain D-2-hydroxy acids (such as D-2-hydroxybutyrate, DL-2-hydroxyvalerate, and
347
DL-2-hydroxyisocaproate),
348 349
acids. Although the specific activity of GOX1253 for D-lactate reached
up to three times its activity towards D-lactate (Fig. 5A).
With regard to different electron acceptors, GOX1253 and GOX2071 showed distinct preferences (Table 5). GOX1253 preferred to use dichlorophenol-indophenol 15
350
(DCPIP) as an electron acceptor and showed moderate activity using MTT and
351
K3[Fe(CN)6]. However, it had extremely low specific activity when using O2 as an
352
electron acceptor (about 477 times lower than that with DCPIP). Comparatively,
353
GOX2071 showed nearly equal specific activity with DCPIP, MTT, and O2 as electron
354
acceptors.
355
To confirm the classification of GOX1253 and GOX2071, their abilities to use O2 as
356
a direct electron acceptor were assessed using a Clark-type oxygen electrode as described
357
in a previous study (34). Purified enzyme (0.016 U/ml) was added to a reaction chamber
358
containing 50 mM Tris-HCl (pH 7.4) and 20 mM D-lactate. Little O2 consumption was
359
detected after the addition of GOX1253 for 2 min, while rapid O2 consumption was
360
observed when PMS was added (Fig. 5B), indicating that GOX1253 is a typical D-iLDH.
361
O2 consumption was noticeable immediately following the addition of GOX2071, and the
362
rate of O2 consumption did not vary after the addition of PMS (Fig. 5B), suggesting that
363
GOX2071 can use O2 as a direct electron acceptor to oxidize D-lactate. GOX2071
364
appears to be a novel type of D-iLDH, a D-lactate oxidase.
365
Catalytic mechanism of GOX2071. L-Lactate oxidase has been studied and used in
366
biosensors for many years (16, 35). The enzyme catalyzes the oxidation of L-lactate into
367
pyruvate and hydrogen peroxide using O2 as a direct electron acceptor. In order to
368
elucidate the catalytic mechanism of GOX2071, five aerobic reaction systems were
369
assessed at 30°C for 30 min, as shown in Table 6. Catalase was added to the system to
370
transform hydrogen peroxide, a possible product, into H2O and O2. Pyruvate and acetate
371
were found as products in system 1, which contained GOX2071 and D-lactate. When
372
catalase was added, as in system 2, pyruvate rather than acetate became the main product,
373
which suggested that catalase stopped the oxidation of pyruvate to acetate by catalyzing 16
374
the decomposition of H2O2. System 3 showed that GOX2071 could not convert pyruvate
375
to acetate, which confirmed the previous supposition. Systems 4 and 5 were used to
376
demonstrate that H2O2 rather than GOX2071 oxidized pyruvate to acetate. The results
377
showed that artificially added H2O2 oxidized pyruvate to acetate without the need for an
378
enzyme and that catalase stopped the oxidization. Thus, the results indicated that
379
GOX2071, a D-lactate oxidase, catalyzed the oxidation of D-lactate to pyruvate and H2O2
380
and that the generated H2O2 oxidized pyruvate to acetate, as schemed in the following
381
reactions.
382 383
The kinetic parameters of purified GOX2071 were evaluated using a Clark-type
384
oxygen electrode. The estimated apparent Km and Vmax of GOX2071 towards D-lactate
385
were 3.62 ± 0.53 mM and 0.52 ± 0.05 U/mg, respectively (Table 7). The data is similar to
386
that reported for L-lactate oxidase from Geotrichum candidum (Km 3.6 mM, Vmax 1.26
387
U/mg) (36).The estimated apparent Km and Vmax for O2, the other substrate, were 0.16 ±
388
0.01 mM and 0.97 ± 0.03 U/mg, respectively (Table 7).
389
Physiological functions of GOX1253 and GOX2071. To clarify the roles of
390
GOX1253 and GOX2071 in D-lactate utilization in vivo, the D-lactate oxidizing capacity
391
of whole cells of G. oxydans 621H wild-type and mutant strains were tested. The reaction
392
broths contained 20 mM phosphate buffer (pH 7.0), 85 mM D-lactate, and 100 g/l wet
393
cells at 30°C and 180 rpm. Rapid consumption of D-lactate by G. oxydans 621H wild-type
394
cells was observed, whereas almost no perceivable D-lactate consumption was found in
395
reaction broths containing G. oxydans ΔGOX1253 or G. oxydans ΔGOX1253 ΔGOX 2071
396
cells (Fig. S2). These results indicated that the cells lost their ability to oxidize D-lactate 17
397
when GOX1253 was deleted. In contrast, the deletion of GOX2071 had no apparent
398
effect on the D-lactate oxidation in G. oxydans 621H (Fig. S2).
399
To investigate the physiological roles of GOX1253 and GOX2071 in the growth of G.
400
oxydans 621H on D-lactate, G. oxydans 621H and its derivatives were cultivated in YE-P
401
medium supplemented with 50 mM D-lactate. As expected, all G. oxydans 621H-derived
402
strains containing GOX1253 were capable of utilizing D-lactate to support their growth,
403
while strains lacking GOX1253 were not (Fig. 6A and Fig. 6B). These results strongly
404
suggest that GOX1253 is the key enzyme that supports the growth of G. oxydans 621H on
405
D-lactate.
406
oxidation by GOX2071, GOX2071 did not contribute to the D-lactate-driven growth of G.
407
oxydans 621H.
Because no usable energy or carbon source was produced from D-lactate
408 409
DISCUSSION
410
In this study, D-lactate was identified as one of a few available organic acids that can act
411
as an energy source to support the growth of G. oxydans 621H. The oxidized product,
412
pyruvate, did not support the growth of G. oxydans 621H. The energy obtained from
413
D-lactate
414
on D-lactate. Consequently, the enzymes responsible for D-lactate oxidation in G. oxydans
415
621H and their mechanisms were the focus of this study. Enzyme activity analysis of G.
416
oxydans 621H wild-type and mutants identified two D-lactate oxidizing enzymes,
417
GOX1253 and GOX2071, with differential subcellular distributions (Table 4). GOX1253
418
is located on the cytoplasmic membrane of G. oxydans 621H. In contrast, GOX2071 is a
419
soluble protein located in the cytoplasm.
420
oxidation would be the major driving force for the growth of G. oxydans 621H
Comparison of the GOX1253 sequence with the GenBank database using the 18
421
BLAST program showed that the predicted FAD-binding domain of GOX1253 is located
422
near the N-terminus of the protein, while the C-terminus contains a predicted
423
membrane-bound lactate dehydrogenase domain. The predicted domains of GOX1253 are
424
similar to that of respiratory D-iLDH from E. coli (9). The BLASTP result of GOX2071
425
also revealed an FAD-binding domain at the N-terminus, but an FAD-oxidase domain
426
was found at the C-terminus. Furthermore, phylogenetic analyses of GOX1253 and
427
GOX2071 homologs (Fig. 7 and Table S2) show that the enzymes belong to two distinct
428
clusters. GOX1253 is strongly related to E. coli D-iLDH and the D-iLDHs from
429
Proteobacteria that use quinone as a natural electron acceptor; they form a distinct cluster
430
relative to the other D-iLDHs. D-iLDHs similar to GOX2071, which contain only the
431
FAD-binding and FAD-oxidase domains, are found in all three domains of life, unlike
432
quinone-dependent D-iLDHs, which are only found in Bacteria. Moreover, very strong
433
bootstrap support indicates that GOX2071 has a closer phylogenetic relationship to
434
D-iLDHs
from Animalia than to those from Fungi and Plantae (37).
435
Among the reported bacteria, only three strains (Photobacterium profundum,
436
Propionibacterium acnes, and Brevibacterium linens) possess two putative genes
437
encoding D-iLDHs, dld (similar to E. coli D-iLDH) and dld-II (similar to SO_1521 of S.
438
oneidensis MR-1) (32), but their respective functions in these strains have not been
439
reported. In this study, two enzymes for D-lactate oxidation were identified in G. oxydans
440
621H, and their catalytic characteristics, kinetic properties, functions, and physiological
441
significance were investigated. To date, G. oxydans 621H is the only bacterium in which
442
two enzymes have been shown experimentally to oxidize D-lactate. GOX1253 contributes
443
to the rapid oxidization of D-lactate to pyruvate on the membrane (Fig. 6). Subsequently,
444
the synthesized pyruvate is likely to be converted to acetate (Fig. 2D) by pyruvate 19
445
decarboxylase (GOX1081) and aldehyde dehydrogenase (GOX2018) acting sequentially
446
in the cytoplasm (29, 38). Indeed, no alternative pathway for the production of acetate
447
from pyruvate appears to exist in G. oxydans 621H, which lacks phosphotransacetylase
448
(EC 2.3.1.8), acetate kinase (EC 2.7.2.1), and pyruvate:quinone oxidoreductase (EC
449
1.2.2.2) (29). The physiological function of GOX2071, which displayed no perceptible
450
activity in D-lactate oxidation in vivo (Fig. 6), was not clarified in this study. Nevertheless,
451
GOX2071 might also play a role in the oxidation of D-lactate to acetate in the cytoplasm.
452
On the basis of the results and suppositions described above, we propose a model for
453
D-lactate
454
D-lactate,
455
reported. However, L-lactate permease (LldP) and glycolate permease (GlcA) of E. coli
456
can transport D-lactate (39). When searching the G. oxydans 621H genome, GOX2098
457
was found to exhibit high protein sequence identities to E. coli LldP (31.4%) and GlcA
458
(50.5%), suggesting that GOX2098 might transport D-lactate in G. oxydans 621H.
459
oxidation in G. oxydans 621H, as shown in Fig. 8. Regarding the transport of no proteins specific for the transport of D-lactate into the cytoplasm have been
D-Lactate
was used as an energy source in G. oxydans 621H (Fig. 2), unlike in E.
460
coli and C. glutamicum (9, 11). The product of D-lactate oxidation by E. coli or C.
461
glutamicum D-iLDH, pyruvate, is further oxidized to acetyl-CoA by the pyruvate
462
dehydrogenase complex. Then, acetyl-CoA enters into the TCA cycle to provide carbon
463
and energy resources for bacterial growth. However, the TCA cycle and EMP pathway
464
are incomplete in G. oxydans because of the lack of succinate dehydrogenase and
465
6-phosphofructokinase (1). Furthermore, G. oxydans 621H cannot produce C6-sugars via
466
gluconeogenesis; no open reading frames that potentially encode a phosphoenolpyruvate
467
synthase or other phosphoenolpyruvate-synthesizing enzymes have been identified in its
468
genome (1). Therefore, pyruvate derived from D-lactate cannot enter into the TCA cycle 20
469
for further metabolism or for production of C6-sugars via gluconeogenesis, and the
470
accumulated pyruvate must enter a non-energy generation pathway with acetate as the
471
final product. Therefore, the D-lactate-driven growth of G. oxydans depends on the limited
472
energy derived from the oxidation of D-lactate to pyruvate via membrane-bound
473
GOX1253.
474
The crystal structure of respiratory D-iLDH from E. coli has been solved, and its
475
physiological features and properties have been extensively studied (9-10). GOX1253 is
476
also a membrane-bound protein, whose over-expression and purification may be
477
relatively difficult. Thus, E. coli C43 (DE3), a mutant of E. coli BL21 (DE3) suitable for
478
membrane-bound protein expression (40), was used for the over-expression of GOX1253.
479
Purified GOX1253 exhibits similar catalytic characteristics to E. coli D-iLDH, such as
480
high activity towards D-lactate, narrow substrate specificity, incomplete stereoselectivity
481
for the D-isomer (i.e., low but detectable activity towards L-lactate), and a requirement for
482
an artificial electron acceptor for the continuous oxidation of D-lactate (10). Given the
483
rather simple respiratory chain in G. oxydans 621H (1), together with the fact that the
484
energy for growth comes only from D-lactate oxidation via GOX1253, we can speculate
485
on the relationship between GOX1253 and the respiratory chain in cellular energy
486
provision. Membrane-bound GOX1253 transfers two moles of electrons to ubiquinone
487
when oxidizing one mole of D-lactate. Two quinol oxidases, cytochrome bo3 and bd, then
488
catalyze the transfer of electrons from the reduced ubiquinone to molecular oxygen,
489
which is accompanied by the generation of proton motive force (1-2, 41). Subsequently,
490
the electrochemical proton gradient is used to generate ATP via an F1F0-type ATP
491
synthase (2).
492
Unlike other reported D-iLDHs, GOX2071 aerobically oxidizes D-lactate in the 21
493
absence of an artificial electron acceptor (Fig. 5B). This indicates that GOX2071 is the
494
first experimentally confirmed D-lactate oxidase (13). In addition, GOX2071 exhibits
495
high stereoselectivity for D-isomers and broad substrate specificity for D-2-hydroxy acids
496
with different carbon chain lengths (Fig. 5A). Considering its ability to utilize O2 as the
497
direct electron acceptor, GOX2071 has potential for use in the resolution of racemic
498
2-hydroxy acids to produce optically pure L-2-hydroxy acids, which are widely used as
499
pharmaceutical intermediates and platform chemical compounds.
500
D-Lactate
is metabolized in the human body to a limited extent, and its abnormal
501
accumulation causes D-lactic acidosis, a syndrome accompanied by recurrent episodes of
502
encephalopathy and metabolic acidosis (42-44). The clinical diagnosis of D-lactic acidosis
503
must be confirmed by measuring the D-lactate level at the time of an acute attack (42).
504
However, routine lactate determinations only measure L-lactate. Thus, a rapid detection
505
method, such as the D-lactate biosensor, specific for D-lactate is urgently needed (42-43).
506
The widely used L-lactate biosensor is usually based on the amperometric detection of
507
H2O2 released from L-lactate oxidation via L-lactate oxidase (16, 45). Unlike
508
membrane-bound D-iLDHs, which require detergent for stability (13), soluble GOX2071
509
is favorable for immobilization to the electrode surface. On the other hand, the H2O2
510
production capacity of GOX2071 makes it suitable for biosensors, similar to L-lactate
511
oxidase.
512
In summary, our study clarifies the unusual mechanism for the D-lactate-dependent
513
growth of G. oxydans, in which D-lactate is used as an energy source. GOX1253 is the
514
key enzyme providing energy for the growth of G. oxydans 621H, via one-step oxidation
515
of D-lactate accompanied by electron transfer to a quinone pool. In contrast, GOX2071
516
oxidizes D-lactate using O2 as a direct electron acceptor without usable energy production; 22
517
thus, it does not contribute to the D-lactate-driven growth of the strain. Furthermore, the
518
first identified D-lactate oxidase, GOX2071, together with its homologs, will increase
519
interest in the development of new biocatalysts for racemic 2-hydroxy acid resolution and
520
new D-lactate biosensors.
521 522
ACKNOWLEDGMENTS
523
The work was supported by the National Natural Science Foundation of China (31270856
524
and 31170052) and the Chinese National Program for High Technology Research and
525
Development (2014AA021206). We thank Prof. Uwe Deppenmeier (Universität Bonn)
526
for providing the expression vector, pBBR1p264. The authors declare no conflict of
527
interest.
528 529
REFERENCES
530
1.
Prust C, Hoffmeister M, Liesegang H, Wiezer A, Fricke WF, Ehrenreich A,
531
Gottschalk G, Deppenmeier U. 2005. Complete genome sequence of the acetic
532
acid bacterium Gluconobacter oxydans. Nat Biotechnol 23:195–200.
533
http://dx.doi.org/10.1038/nbt1062.
534
2.
Deppenmeier U, Ehrenreich A. 2009. Physiology of acetic acid bacteria in light
535
of the genome sequence of Gluconobacter oxydans. J Mol Microbiol Biotechnol
536
16:69–80. http://dx.doi.org/10.1159/000142895.
537
3.
De Muynck C, Pereira CSS, Naessens M, Parmentier S, Soetaert W,
538
Vandamme EJ. 2007. The genus Gluconobacter oxydans: Comprehensive
539
overview of biochemistry and biotechnological applications. Crit Rev Biotechnol
540
27:147–171. http://dx.doi.org/10.1080/07388550701503584. 23
541
4.
542 543
Gupta A, Singh VK, Qazi GN, Kumar A. 2001. Gluconobacter oxydans:its biotechnological applications. J Mol Microbiol Biotechnol 3:445–456.
5.
Deppenmeier U, Hoffmeister M, Prust C. 2002. Biochemistry and
544
biotechnological applications of Gluconobacter strains. Appl Microbiol
545
Biotechnol 60:233–242. http://dx.doi.org/10.1007/s00253-002-1114-5.
546
6.
Rollini M, Manzoni M. 2005. Bioconversion of D-galactitol to tagatose and
547
dehydrogenase activity induction in Gluconobacter oxydans. Process Biochem
548
40:437–444. http://dx.doi.org/10.1016/j.procbio.2004.01.028.
549
7.
Gao C, Zhang W, Huang Y, Ma C, Xu P. 2012. Efficient conversion of
550
1,2-butanediol to (R)-2-hydroxybutyric acid using whole cells of Gluconobacter
551
oxydans. Bioresour Technol 115:75–78.
552
http://dx.doi.org/10.1016/j.biortech.2011.11.009.
553
8.
Peters B, Mientus M, Kostner D, Junker A, Liebl W, Ehrenreich A. 2013.
554
Characterization of membrane-bound dehydrogenases from Gluconobacter
555
oxydans 621H via whole-cell activity assays using multideletion strains. Appl
556
Microbiol Biotechnol 97:6397–6412.
557
http://dx.doi.org/10.1007/s00253-013-4824-y.
558
9.
Dym O, Pratt EA, Ho C, Eisenberg D. 2000. The crystal structure of D-lactate
559
dehydrogenase, a peripheral membrane respiratory enzyme. Proc Natl Acad Sci U
560
S A 97:9413–9418. http://dx.doi.org/10.1073/pnas.97.17.9413.
561
10.
Kohn LD, Kaback HR. 1973. Mechanisms of active transport in isolated
562
bacterial membrane vesicles: XV. Purification and properties of the
563
membrane-bound D-lactate dehydrogenase from Escherichia coli. J Biol Chem
564
248:7012–7017. 24
565
11.
Kato O, Youn JW, Stansen KC, Matsui D, Oikawa T, Wendisch VF. 2010.
566
Quinone-dependent D-lactate dehydrogenase Dld (Cg1027) is essential for growth
567
of Corynebacterium glutamicum on D-lactate. BMC Microbiol 10:321.
568
http://dx.doi.org/10.1186/1471-2180-10-321.
569
12.
Ma C, Gao C, Qiu J, Hao J, Liu W, Wang A, Zhang Y, Wang M, Xu P. 2007.
570
Membrane-bound L- and D-lactate dehydrogenase activities of a newly isolated
571
Pseudomonas stutzeri strain. Appl Microbiol Biotechnol 77:91–98.
572
http://dx.doi.org/10.1007/s00253-007-1132-4.
573
13.
Jiang T, Gao C, Ma C, Xu P. 2014. Microbial lactate utilization: enzymes,
574
pathogenesis, and regulation. Trends Microbiol 22:589–599.
575
http://dx.doi.org/10.1016/j.tim.2014.05.008.
576
14.
Zheng Z, Sheng B, Ma C, Zhang H, Gao C, Su F, Xu P. 2012. Relative catalytic
577
efficiency of ldhL- and ldhD-encoded products is crucial for optical purity of
578
lactic acid produced by Lactobacillus strains. Appl Environ Microbiol
579
78:3480–3483. http://dx.doi.org/10.1128/AEM.00058-12.
580
15.
Wang L, Cai Y, Zhu L, Guo H, Yu B. 2014. Major role of NAD-dependent
581
lactate dehydrogenases in high optically pure L-lactic acid production by
582
thermophilic Bacillus coagulans. Appl Environ Microbiol.
583
http://dx.doi.org/10.1128/AEM.01864-14.
584
16.
Rassaei L, Olthuis W, Tsujimura S, Sudhölter EJR, van den Berg A. 2014.
585
Lactate biosensors: current status and outlook. Anal Bioanal Chem 406:123–137.
586
http://dx.doi.org/10.1007/s00216-013-7307-1.
587 588
17.
Burdick BA, Schaeffer JR. 1987. Co-immobilized coupled enzyme systems on nylon mesh capable of gluconic and pyruvic acid production. Biotechnol Lett 25
589 590
9:253–258. http://dx.doi.org/10.1007/BF01027159. 18.
591 592
Xu P, Qiu J, Gao C, Ma C. 2008. Biotechnological routes to pyruvate production. J Biosci Bioeng 105:169–175. http://dx.doi.org/10.1263/jbb.105.169.
19.
Su W, Chang Z, Gao K, Wei D. 2004. Enantioselective oxidation of racemic
593
1,2-propanediol to D-(−)-lactic acid by Gluconobacter oxydans. Tetrahedron:
594
Asymmetry 15:1275–1277. http://dx.doi.org/10.1016/j.tetasy.2004.03.009.
595
20.
Schäfer A, Tauch A, Jäger W, Kalinowski J, Thierbach G, Pühler A. 1994.
596
Small mobilizable multi-purpose cloning vectors derived from the Escherichia
597
coli plasmids pK18 and pK19: selection of defined deletions in the chromosome
598
of Corynebacterium glutamicum. Gene 145:69–73.
599
http://dx.doi.org/10.1016/0378-1119(94)90324-7.
600
21.
Peters B, Junker A, Brauer K, Mühlthaler B, Kostner D, Mientus M, Liebl W,
601
Ehrenreich A. 2013. Deletion of pyruvate decarboxylase by a new method for
602
efficient markerless gene deletions in Gluconobacter oxydans. Appl Microbiol
603
Biotechnol 97:2521–2530. http://dx.doi.org/10.1007/s00253-012-4354-z.
604
22.
Kawai S, Goda-Tsutsumi M, Yakushi T, Kano K, Matsushita K. 2013.
605
Heterologous overexpression and characterization of a flavoprotein-cytochrome c
606
complex fructose dehydrogenase of Gluconobacter japonicus NBRC3260. Appl
607
Environ Microbiol 79:1654–1660. http://dx.doi.org/10.1128/aem.03152-12.
608
23.
Kallnik V, Meyer M, Deppenmeier U, Schweiger P. 2010. Construction of
609
expression vectors for protein production in Gluconobacter oxydans. J Biotechnol
610
150:460–465. http://dx.doi.org/10.1016/j.jbiotec.2010.10.069.
611 612
24.
Dumon-Seignovert L, Cariot G, Vuillard L. 2004. The toxicity of recombinant proteins in Escherichia coli: a comparison of overexpression in BL21(DE3), 26
613
C41(DE3), and C43(DE3). Protein Expr Purif 37:203–206.
614
http://dx.doi.org/10.1016/j.pep.2004.04.025.
615
25.
Markwell MAK, Haas SM, Bieber LL, Tolbert NE. 1978. A modification of the
616
Lowry procedure to simplify protein determination in membrane and lipoprotein
617
samples. Anal Biochem 87:206–210.
618
http://dx.doi.org/10.1016/0003-2697(78)90586-9.
619
26.
Gao C, Jiang T, Dou P, Ma C, Li L, Kong J, Xu P. 2012. NAD-independent
620
L-lactate
621
stutzeri SDM. PLoS One 7:e36519.
622
http://dx.doi.org/10.1371/journal.pone.0036519.
623
27.
dehydrogenase is required for L-lactate utilization in Pseudomonas
Eppink MHM, Boeren SA, Vervoort J, van Berkel WJH. 1997. Purification
624
and properties of 4-hydroxybenzoate 1-hydroxylase (decarboxylating), a novel
625
flavin adenine dinucleotide-dependent monooxygenase from Candida
626
parapsilosis CBS604. J Bacteriol 179:6680–6687.
627
28.
Li L, Li K, Wang Y, Chen C, Xu Y, Zhang L, Han B, Gao C, Tao F, Ma C, Xu
628
P. 2015. Metabolic engineering of Enterobacter cloacae for high-yield production
629
of enantiopure (2R,3R)-2,3-butanediol from lignocellulose-derived sugars. Metab
630
Eng 28:19-27. http://dx.doi.org/10.1016/j.ymben.2014.11.010.
631
29.
Krajewski V, Simić P, Mouncey NJ, Bringer S, Sahm H, Bott M. 2010.
632
Metabolic engineering of Gluconobacter oxydans for improved growth rate and
633
growth yield on glucose by elimination of gluconate formation. Appl Environ
634
Microbiol 76:4369–4376. http://dx.doi.org/10.1128/AEM.03022-09.
635 636
30.
Reed DW, Hartzell PL. 1999. The Archaeoglobus fulgidus D-lactate dehydrogenase is a Zn2+ flavoprotein. J Bacteriol 181:7580–7587. 27
637
31.
Stansen C, Uy D, Delaunay S, Eggeling L, Goergen JL, Wendisch VF. 2005.
638
Characterization of a Corynebacterium glutamicum lactate utilization operon
639
Induced during temperature-triggered glutamate production. Appl Environ
640
Microbiol 71:5920–5928. http://dx.doi.org/10.1128/aem.71.10.5920-5928.2005.
641
32.
Pinchuk GE, Rodionov DA, Yang C, Li X, Osterman AL, Dervyn E,
642
Geydebrekht OV, Reed SB, Romine MF, Collart FR, Scott JH, Fredrickson
643
JK, Beliaev AS. 2009. Genomic reconstruction of Shewanella oneidensis MR-1
644
metabolism reveals a previously uncharacterized machinery for lactate utilization.
645
Proc Natl Acad Sci U S A 106:2874–2879.
646
http://dx.doi.org/10.1073/pnas.0806798106.
647
33.
Reddy Pagala V, Park J, Reed DW, Hartzell PL. 2002. Cellular localization of
648
D-lactate
649
Archaea 1:95–104. http://dx.doi.org/10.1155/2002/297264.
650
34.
dehydrogenase and NADH oxidase from Archaeoglobus fulgidus.
Yuan H, Fu G, Brooks PT, Weber I, Gadda G. 2010. Steady-state kinetic
651
mechanism and reductive half-reaction of D-arginine dehydrogenase from
652
Pseudomonas aeruginosa. Biochemistry 49:9542–9550.
653
http://dx.doi.org/10.1021/bi101420w.
654
35.
655 656
Lockridge O, Massey V, Sullivan PA. 1972. Mechanism of action of the flavoenzyme lactate oxidase. J Biol Chem 247:8097–8106.
36.
Sztajer H, Wang W, Lünsdorf H, Stocker A, Schmid RD. 1996. Purification
657
and some properties of a novel microbial lactate oxidase. Appl Microbiol
658
Biotechnol 45:600–606. http://dx.doi.org/10.1007/s002530050736.
659 660
37.
Engqvist M, Drincovich MF, Flügge U-I, Maurino VG. 2009. Two D-2-hydroxy-acid
dehydrogenases in Arabidopsis thaliana with catalytic 28
661
capacities to participate in the last reactions of the methylglyoxal and β-oxidation
662
pathways. J Biol Chem 284:25026–25037.
663
http://dx.doi.org/10.1074/jbc.M109.021253.
664
38.
Richhardt J, Bringer S, Bott M. 2012. Mutational analysis of the pentose
665
phosphate pathway and the Entner-Doudoroff pathway in Gluconobacter oxydans
666
reveals improved growth of an Δedd Δeda deletion mutant on mannitol. Appl
667
Environ Microbiol 78:6975–6986. http://dx.doi.org/10.1128/AEM.01166-12.
668
39.
Núñez MF, Kwon O, Wilson TH, Aguilar J, Baldoma L, Lin ECC. 2002.
669
Transport of L-lactate, D-lactate, and glycolate by the LldP and GlcA membrane
670
carriers of Escherichia coli. Biochem Biophys Res Commun 290:824–829.
671
http://dx.doi.org/10.1006/bbrc.2001.6255.
672
40.
Miroux B, Walker JE. 1996. Over-production of proteins in Escherichia coli:
673
mutant hosts that allow synthesis of some membrane proteins and globular
674
proteins at high levels. J Mol Biol 260:289–298.
675
http://dx.doi.org/10.1006/jmbi.1996.0399.
676
41.
Richhardt J, Luchterhand B, Bringer S, Büchs J, Bott M. 2013. Evidence for a
677
key role of cytochrome bo3 qxidase in respiratory energy metabolism of
678
Gluconobacter oxydans. J Bacteriol 195:4210–4220.
679
http://dx.doi.org/10.1128/jb.00470-13.
680
42.
Vella A, Farrugia G. 1998. D-Lactic acidosis: pathologic consequence of
681
saprophytism. Mayo Clin Proc 73:451–456.
682
http://dx.doi.org/10.1016/S0025-6196(11)63729-4.
683 684
43.
Inoue Y, Shinka T, Ohse M, Kohno M, Konuma K, Ikawa H, Kuhara T. 2007. Changes in urinary level and configuration ratio of D-lactic acid in patients with 29
685
short bowel syndrome. J Chromatogr B 855:109–114.
686
http://dx.doi.org/10.1016/j.jchromb.2007.02.052.
687
44.
Reddy VS, Patole SK, Rao S. 2013. Role of probiotics in short bowel syndrome
688
in infants and children—a systematic review. Nutrients 5:679–699.
689
http://dx.doi.org/10.3390/nu5030679.
690
45.
Iwuoha EI, Rock A, Smyth MR. 1999. Amperometric L-lactate biosensors: 1.
691
Lactic acid sensing electrode containing lactate oxidase in a composite
692
poly-L-lysine matrix. Electroanalysis 11:367–373.
693
http://dx.doi.org/10.1002/(sici)1521-4109(199905)11:53.0.co;
694
2-0.
695
30
696
FIGURE LEGENDS
697
FIG 1 Comparison of the growth of G. oxydans 621H on different organic compounds. G.
698
oxydans 621H was cultured in YE-P medium supplemented with 50 mM of D-glucose,
699
1,2-propanediol, and 19 proteinaceous amino acids (A) or 24 organic acids (B),
700
respectively. Growth (∆OD600 nm) was calculated by the final OD reached at 24 h minus
701
the initial OD at 600 nm. A slight growth of G. oxydans 621H in YE-P medium (control)
702
might be caused by small amounts of utilizable organic compounds residing in the
703
inoculated cells, or provided by yeast extracts and peptone. All error bars represent the
704
standard deviations of at least three independent experiments.
705 706
FIG 2 The impacts of D-lactate and pyruvate on the growth of G. oxydans 621H in YE-P
707
medium. G. oxydans 621H was cultured in YE-P medium (as control) and YE-P medium
708
supplemented with 50 mM D-lactate or 50 mM pyruvate, respectively. Cell density (A),
709
D-lactate
710
the standard deviations of three independent experiments.
(B), pyruvate (C), and acetate (D) in mediums were assayed. Error bars indicate
711 712
FIG 3 Purification and characterization of GOX1253. (A) SDS-PAGE of expression and
713
purification steps of GOX1253. Lane M, molecular weight markers; lane 1, crude extract
714
of E. coli C43 (DE3) harboring pET25b; lane 2, crude extract of E. coli C43 (DE3)
715
harboring pET25b-GOX1253; lane 3, purified GOX1253 using a HisTrap column. (B)
716
Size-exclusion chromatography analysis of active GOX1253 using thyroglobulin (669
717
kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa), ovalbumin (43 kDa),
718
and ribonuclease A (13.7 kDa) as standard proteins. (C) HPLC analysis of flavin bounded
719
to GOX1253 using FAD, FMN and riboflavin as reference standards. (D) Analysis of the 31
720
product of the GOX1253 catalyzed D-lactate dehydrogenation. The reaction system (red
721
line) containing 50 mM Tris-HCl (pH 7.4), 20 mM D-lactate, 2 U/ml purified GOX1253,
722
and 1 mM MTT was incubated aerobically at 30°C and 180 rpm for 30 min and then
723
subjected to HPLC analysis. The reactions with denatured GOX1253 (black line) or
724
without MTT (green line) addition were also conducted under identical conditions.
725 726
FIG 4 Purification and characterization of GOX2071. (A) SDS-PAGE of expression and
727
purification steps of GOX2071. Lane M, molecular weight markers; lane 1, crude extract
728
of E. coli C43 (DE3) harboring pET25b; lane 2, crude extract of E. coli C43 (DE3)
729
harboring pET25b-GOX2071; lane 3, partially purified GOX2071 using a Source 30Q
730
column; lane 4, purified GOX2071 using a HisTrap column. (B) Size-exclusion
731
chromatography analysis of GOX2071 as described in Fig. 3B. (C) HPLC analysis of
732
flavin bounded to GOX2071 using FAD, FMN and riboflavin as reference standards. (D)
733
Analysis of the product of the GOX2071 catalyzed D-lactate dehydrogenation. Three
734
reactions with purified GOX2071 of 2 U/ml were conducted as described in Fig. 3D and
735
then subjected to HPLC analysis.
736 737
FIG 5 Difference between GOX1253 and GOX2071 on substrate specificity and
738
reactivity with molecular oxygen. (A) Specific activities of GOX1253 and GOX2071
739
towards sodium salts of different 2-hydroxy acids (50 mM) with MTT as the electron
740
acceptor. All error bars indicate the standard deviations of three independent experiments.
741
(B) D-Lactate-dependent oxygen consumption of GOX1253 and GOX2071 assayed by a
742
Clark-type oxygen electrode. The assay mixture contained 50 mM Tris-HCl (pH 7.4) and
743
20 mM D-lactate at 30°C at 900 rpm. After monitoring the background for about 1 min, 32
744
GOX1253 or GOX2071 (0.016 U/ml) was added and the oxygen traces were monitored.
745
Later (about 2 min), 0.4 mM PMS was added, and the oxygen traces were monitored for
746
another 2 min. Addition of PMS solution (air-saturated) would cause a slight increase of
747
oxygen concentration in reaction mixture as indicated.
748 749
FIG 6 Identification of the roles of GOX1253 and GOX2071 in the D-lactate-dependent
750
growth of G. oxydans 621H. The G. oxydans 621H (WT) and its derivatives were cultured
751
in YE-P medium supplemented with 50 mM D-lactate and the changes of cell density (A)
752
and D-lactate concentration (B) were assayed. Error bars indicate the standard deviations
753
of three independent experiments.
754 755
FIG 7 Phylogenetic analyses of GOX2071 and GOX1253. Proteins including
756
quinone-dependent D-iLDHs similar to GOX1253, Fe-S clusters containing D-iLDHs and
757
the D-iLDHs similar to GOX2071 in the three domains of life are listed in Table S2. The
758
phylogenetic tree was constructed by using MEGA software program (version 5.10) via
759
neighbor-joining and bootstrap method for 1000 replications with Poisson correction. The
760
asterisk marked that the bacteria do not belong to the same phylum with their neighbours.
761
Mastigocoleus testarum belongs to Cyanobacteria; Flavobacterium saliperosum belongs
762
to Bacteroidetes; and Corynebacterium glutamicum belongs to Actinobacteria. The scale
763
at the bottom indicates levels of amino acid sequence divergence.
764 765
FIG 8 Proposed model for D-lactate oxidation in G. oxydans 621H. The intracellular
766
oxidation of D-lactate can be catalyzed by both GOX1253 and GOX2071. GOX2071
767
oxidizes D-lactate directly via O2 in a way that GOX2071 does not provide any usable 33
768
energy for cells. GOX1253 contributes a lot to oxidize D-lactate to pyruvate rapidly on
769
the membrane, which is accompanied by the transport of electrons to the ubiquinone
770
pools to provide energy for the strain. Subsequently, pyruvate is converted to acetate by
771
pyruvate decarboxylase (GOX1081) and aldehyde dehydrogenase (GOX2018) acting
772
sequentially in the cytoplasm. D-Lactate might be transported via the lactate permease
773
(LldP) encoded by GOX2098.
774
34
775
TABLE 1 Strains and plasmids used in this study Strain G. oxydans 621H G. oxydans ΔGOX1253 G. oxydans ΔGOX2071 G. oxydans ΔGOX1253 ΔGOX2071 G. oxydans GOX1253 complement G. oxydans GOX2071 complement E. coli DH5α E. coli HB101 E. coli C43 (DE3) Plasmid pRK2013 pET25b pET25b-GOX1253 pET25b-GOX2071 pK18mobsacB pK18mobsacB-ΔGOX1253 pK18mobsacB-ΔGOX2071
776
Characteristics G. oxydans DSM2343, wild type, Cefr GOX1253 deletion strain of G. oxydans 621H, Cefr GOX2071 deletion strain of G. oxydans 621H, Cefr GOX1253 and GOX2071 deletion strain of G. oxydans 621H, Cefr G. oxydans ΔGOX1253 ΔGOX2071 harboring pBBR1p264-GOX1253, Cefr, Kmr G. oxydans ΔGOX1253 ΔGOX2071 harboring pBBR1p264-GOX2071, Cefr, Kmr F– φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 hsdR17(rK–, mK+) phoA supE44 thi-1 gyrA96 relA1 λ–, used for gene clone F– mcrB mrr hsdS20(rB–, mB–) recA13 supE44 ara14 galK2 lacY1 proA2 rpsL20(Smr) xy15 λ– leu mtl1, used for triparental mating as the helper strain Mutant of E. coli BL21 (DE3) for protein expression r
Vector mediates plasmid transfer; Km Vector for protein expression, Apr pET25b with GOX1253 gene of G. oxydans 621H, Apr pET25b with GOX2071 gene of G. oxydans 621H, Apr Allelic exchange vector, oriColE1 Mob+, lacZα, sacB,Kmr A pK18mobsacB derivative for deletion of GOX1253, Kmr A pK18mobsacB derivative for deletion of GOX2071, Kmr Expression vector with a strong promoter derived from pBBR1MCS-2 for protein pBBR1p264 production in Gluconobacter oxydans, Kmr pBBR1p264-GOX1253 pBBR1p264 with GOX1253 gene of G. oxydans 621H, Kmr pBBR1p264-GOX2071 pBBR1p264 with GOX2071 gene of G. oxydans 621H, Kmr a DSMZ, Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany.
Source or reference DSMZa This study This study This study This study This study Invitrogen Invitrogen (24) Invitrogen Novagen This study This study (20) This study This study (23) This study This study
35
777
TABLE 2 Sequences of primers used in this study Primer
Sequence (5’→3’) and properties
GOX1253up.f
GGAATTCGATGTCAGCGTCACTAAAAGGC (EcoRI)
GOX1253up.r
ACGATGTCTTCAGCGCAGACGACCTGCTTG
GOX1253down.f CAAGCAGGTCGTCTGCGCTGAAGACATCGT GOX1253down.r TAAAAGCTTTCAGACGCTCTCGGCAACC (HindIII) GOX2071up.f
CCGGAATTCGATGCCGGAACCAGTCATGACCG (EcoRI)
GOX2071up.r
CACATGGCCCAGAAGTGACAGATCGAGGCT
GOX2071down.f AGCCTCGATCTGTCACTTCTGGGCCATGTG GOX2071down.r CCCAAGCTTTCAGCCCGTGTAAACAGCACC (HindIII) GOX1253C.f
GGGCATATGTCAGCGTCACTAAAAGGC (NdeI)
GOX1253C.r
TAAAAGCTTGACGCTCTCGGCAACCCAGTT (HindIII)
GOX2071C.f
AAGCATATGCCGGAACCAGTCATGA (NdeI)
GOX2071C.r
CAACTCGAGGCCCGTGTAAACAGCA (XhoI)
778 779
TABLE 3 Analysis on distribution of iLDHs in G. oxydans 621H using
780
ultracentrifugation Cell fraction
Specific activity (U/mg) D-iLDH
L-iLDH
Crude cell extract
0.15 ± 0.01
0.02 ± 0.00
Ultracentrifugation supernatant
0.02 ± 0.00
0.01 ± 0.00
Membrane fractions
0.40 ± 0.02
0.05 ± 0.00
781 782
36
783
TABLE 4 Location of GOX1253 and GOX2071 in G. oxydans 621H Specific activity of D-iLDH (U/mg) Strain G. oxydans ΔGOX1253
784
Ultracentrifugation
Membrane
supernatant
fractions
(0.50 ± 0.44) × 10-2
ND
a
G. oxydans ΔGOX2071
ND
0.41 ± 0.03
G. oxydans ΔGOX1253 ΔGOX2071
ND
ND
G. oxydans GOX2071 complement
(0.31 ± 0.10) × 10-2
ND
G. oxydans GOX1253 complement
0.58 ± 0.01
5.31 ± 0.15
a
ND, not detectable.
785 786
TABLE 5 Specific activities of GOX1253 and GOX2071 with different electron
787
acceptors Enzyme
Specific activity (U/mg)a DCPIP
MTT
K3[Fe(CN)6]
O2
GOX1253
54.23 ± 0.25
15.75 ± 0.83
6.01 ± 0.31
0.11 ± 0.03
GOX2071
0.61 ± 0.01
0.43 ± 0.01
3.95 ± 0.04
0.58 ± 0.02
788
a
789
Tris-HCl (pH 7.4), 20 mM D-lactate, appropriate amount of enzyme, and different
790
electron acceptors (0.05 mM DCPIP detected at 600 nm, 0.2 mM MTT at 578 nm, and 10
791
mM K3[Fe(CN)6] at 420 nm using a spectrophotometer, or 0.23 mM O2 at 900 rpm using
792
a Clark-type oxygen electrode).
The specific activities were examined in the reaction mixture containing 50 mM
37
793
TABLE 6 Identification of GOX2071 as a D-lactate oxidase System
Ingredients in reaction brothsa
Residual chemicals after reactionb
1.6 U/ml
20 mM
20 mM
100 U/ml
20 mM
D-Lactate
Pyruvate
GOX2071
D-lactate
pyruvate
catalase
H2O2
(mM)
(mM)
(mM)
1
+
+
–
–
–
10.14
2.03
7.59
2
+
+
–
+
–
11.49
8.53
0.22
3
+
–
+
–
–
NDc
20.35
ND
4
–
–
+
–
+
ND
0.46
19.55
5
–
–
+
+
+
ND
18.63
1.00
number
794
a
795
b
The data is the mean of three independent experiments.
796
c
ND, not detectable.
Acetate
Five aerobic reactions were conducted in the 50 mM Tris-HCl buffer (pH 7.4) at 30°C for 30 min.
797 798
TABLE 7 Apparent Km and Vmax of D-lactate and O2 for GOX2071 using a Clark-type oxygen electrode Km
Vmax
kcat
kcat/Km
(mM)
(U/mg)
(s-1)
(M-1 s-1)
D-Lactate
3.62 ± 0.53
0.52 ± 0.04
0.47 ± 0.04
129.74 ± 11.39
O2
0.16 ± 0.01
0.97 ± 0.03
0.87 ± 0.03
5423.59 ± 187.19
Substrate
799
38